Syensqo considers sale of Performance & Care division to focus on speciality chemicals

Belgian chemicals manufacturer Syensqo has announced a strategic review of its Performance & Care division, signalling a potential sale as part of its broader portfolio optimisation strategy. The division, which includes the Novecare and Technology Solutions business units, serves diverse industries such as coatings, personal care, agriculture, and mining. In 2025, the division generated EUR 2.0 billion in sales and EUR 358 million in underlying EBITDA.

According to CEO Mike Radossich, the initiative reflects the company’s intent to focus on high-growth markets, including aerospace, defence, electronics, energy, and mobility. “We will now evaluate a range of strategic options for the Performance & Care segment, with an emphasis on maximising long-term value for our shareholders,” Radossich commented. However, no timeline or definitive decision regarding the sale has been established.

Moerdijk plant in potential transaction

The division’s production facility in Moerdijk, the Netherlands, plays a key role within the Novecare business. The site produces surfactants and specialty chemical ingredients used in coatings, personal care, and industrial applications. Should the division be sold, the Moerdijk plant is expected to be part of the transaction.

Syensqo, which was spun off from Solvay in 2023, aims to transform into a pure-play speciality chemicals and advanced materials company. This strategic shift aligns with ongoing trends in the chemical industry, where companies increasingly focus on innovation-driven and sustainable solutions.

The strategic review underscores Syensqo’s efforts to sharpen its capital allocation and pursue long-term growth opportunities in structurally attractive markets. Further updates on the process are expected, although the company has emphasised that there is no certainty regarding the outcome or structure of a potential transaction.

• Save article in bookmarks
• Print this article